表紙
市場調查報告書

冠狀動脈支架市場分析:各產品(傳統金屬支架,藥劑溶出性血管支架,生物吸收性血管支架),及市場區隔預測

Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027

出版商 Grand View Research, Inc. 商品編碼 374559
出版日期 內容資訊 英文 110 Pages
商品交期: 2-3個工作天內
價格
冠狀動脈支架市場分析:各產品(傳統金屬支架,藥劑溶出性血管支架,生物吸收性血管支架),及市場區隔預測 Coronary Stents Market Size, Share & Trends Analysis Report By Product (Bare Metal Stents, Drug Eluting Stents, Bioresorbable Vascular Scaffold), By Region (North America, Europe, APAC, Latin America, MEA), And Segment Forecasts, 2020 - 2027
出版日期: 2020年03月16日內容資訊: 英文 110 Pages
簡介

本報告提供全球冠狀動脈支架市場相關調查,市場概要和今後預測,彙整各市場區隔及地區別趨勢,及加入此市場的主要企業簡介等資料。

第1章 調查方法

第2章 摘要整理

第3章 市場摘要

第4章 市場變動,趨勢,範圍

  • 市場區隔和範圍
  • 推動市場的要素分析
  • 阻礙市場的要素分析
  • 滲透及成長預測製圖
  • SWOT分析

第5章 市場類別1:產品預測及趨勢分析

  • 產品趨勢分析及市場佔有率
  • 市場規模與預測,及趨勢分析
    • 傳統金屬支架
    • 藥劑溶出性血管支架
    • 生物吸收性血管支架

第6章 市場類別2:各地區預測及趨勢分析

  • 各地區趨勢分析與市場佔有率
  • 市場規模與預測及趨勢分析
    • 北美
    • 歐洲
    • 亞太地區
    • 南美
    • 中東·非洲

第7章 競爭環境

  • 策略性架構
  • 企業簡介

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GVR-1-68038-106-1

The global coronary stents market size is expected to reach USD 11.3 billion by 2027, expanding at a CAGR of 4.7%, according to a new report by Grand View Research, Inc. Increasing adoption of minimally invasive surgeries and percutaneous coronary intervention (PIC) procedures is expected to drive the market for coronary stents in the coming years. Moreover, increasing geriatric population is considered as a high impact rendering driver for the growth of this industry over the forecast period. Technological advancement in 2nd generation drug eluting stents (DES) is further fueling the growth. Development of biodegradable and polymer free DES in order to increase patient compliance is expected to drive the market over the coming years.

The coronary stent market is driven by reimbursement coverage provided by the general public Center for Medicare and Medicaid Services (CMS) and private payers. The coverage is availed under national coverage determination for carotid artery stenting, including products and service provider. From January 2020, Centers for Medicare & Medicaid Services (CMS) proposed reimbursement for some angioplasty and stenting procedures performed in ambulatory surgical center (ASC), which is expected to boost market revenue over the forecast period.

Further key findings from the report suggest:

In terms of revenue, the DES dominated the product segment as of 2019. New product launches and technological advancements in 2nd gen DES are acting as the driving factor for this segment

Prices for the first-generation BVS (Bioresorbable Vascular Scaffold) are much high as compared to existing BMS (Bare Metal Stent) and DES. Due to its safety concern and high hospitalization rates, doctors are not preferring BRS over DES. Moreover, high crossing profile and bulky struts are factors majorly impeding the BRS market

Asia Pacific is expected to exhibit the highest growth rate over the forecast period. Increase in disposable income and growing incidence of heart diseases will fuel market growth in the coming years

Some of the key companies present in the coronary stent market are Medtronic, Abbott, Boston Scientific, Terumo Corporation, Biotronik, and Microport Corporation

With USD 2.3 billion R&D expenditure in 2018, Abbott is anticipated to provide with technologically advanced second generation DES and may be BVS in near future.

Table of Contents

Chapter 1 Research Methodology

  • 1.1 Research Methodology
  • 1.2 Information Procurement
    • 1.2.1 Purchased Database:
    • 1.2.2 GVR's Internal Database
    • 1.2.3 Secondary Sources
    • 1.2.4 Primary Research:
    • 1.2.5 Details Of Primary Research
  • 1.3 Information or Data Analysis
    • 1.3.1 Data Analysis Models
  • 1.4 Market Formulation & Validation
  • 1.5 Model Details
    • 1.5.1 Commodity Workflow Analysis (Model 1)
  • 1.6 List of Secondary Sources
  • 1.7 List of Primary Sources
  • 1.8 Abbreviations
  • 1.9 Report Objectives

Chapter 2 Executive Summary

  • 2.1 Market Snapshot

Chapter 3 Industry Outlook

  • 3.1 Market Segmentation
  • 3.2 Market Lineage Outlook
    • 3.2.1 Parent Market Analysis
    • 3.2.2 Ancillary Market Analysis
  • 3.3 Market Variable Analysis
    • 3.3.1 Market Driver Analysis
      • 3.3.1.1 Rising burden of Cardiovascular Diseases (CVDs)
      • 3.3.1.2 Government initiatives to reduce cost of coronary stents
      • 3.3.1.3 Advancements in stenting technologies
    • 3.3.2 Market Restraint Analysis
      • 3.3.2.1 Stringent regulation and approval
      • 3.3.2.2 Product recall and failure
    • 3.3.3 Industry Chanllenges
      • 3.3.3.1 Risk associated with coronary stent post procedure
  • 3.4 Penetration & Growth Prospect Mapping
  • 3.5 User Perspective Analysis
    • 3.5.1 Consumer Behavior Analysis
    • 3.5.2 Market Influencer Analysis
  • 3.6 Pricing Analysis
  • 3.7 Technology Overview
  • 3.8 Regulatory Framework
    • 3.8.1 Regulatory Landscape
    • 3.8.2 Reimbursement Framework
      • 3.8.2.1 CPT Coding implications
      • 3.8.2.2 HCPCS Coding implications
    • 3.8.3 Cms New Reimbursement Policy For Pci
  • 3.9 Product Pipeline/Clinical Trial Analysis
  • 3.10 R&D Expenditure Analysis
  • 3.11 Estimated R&D Expenditure On Various Types Of Stents (2014 - 2019)
  • 3.12 Product Recalls
  • 3.13 Business Environment Analysis tools
    • 3.13.1 Swot Analysis, By Pest
    • 3.13.2 Porter's Five Forces Analysis

Chapter 4 Coronary Stents Market: Competitive Analysis

  • 4.1 Market Participation Categorization
  • 4.2 Competitive Dashboard Analysis
  • 4.3 Innovators
  • 4.4 Recent Innovations
  • 4.5 Public Companies
    • 4.5.1 Company Market Share Analysis
    • 4.5.2 Company Market Position Analysis
    • 4.5.3 Heat Map Analysis
  • 4.6 Vendor Landscape
    • 4.6.1 List Of Coronary Stent Providers

Chapter 5 Product Segment Analysis

  • 5.1 Coronary Stents Market: Product Movement Analysis
  • 5.2 Bare Metal Stents
    • 5.2.1 Bare Metal Stents Market, 2016 - 2027 (USD Million)
  • 5.3 Drug Eluting Stents
    • 5.3.1 Drug Eluting Stents Market, 2016 - 2027 (USD Million)
    • 5.3.2 Biodegradable Drug Eluting Stents
      • 5.3.2.1 biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
    • 5.3.3 Non-Biodegradable Drug Eluting Stents
      • 5.3.3.1 non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • 5.4 Bioresorbable Vascular Scaffolds
    • 5.4.1 Bioresorbable Vascular Scaffolds Market, 2016 - 2027 (USD Million)

Chapter 6 Coronary Stents Market: Regional Estimates & Trend Analysis, by Product

  • 6.1 Coronary Stents Market Share by Region, 2019 & 2027
  • 6.2 North America
    • 6.2.1 North America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.2.2 U.S.
      • 6.2.2.1 U.S. Coronary Stents market, 2016 - 2027 (USD Million)
    • 6.2.3 Canada
      • 6.2.3.1 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • 6.3 Europe
    • 6.3.1 Europe Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.3.2 U.K.
      • 6.3.2.1 U.K. coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.3 Germany
      • 6.3.3.1 Germany coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.4 France
      • 6.3.4.1 France coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.5 Italy
      • 6.3.5.1 Italy coronary stents market, 2016 - 2027 (USD Million)
    • 6.3.6 Spain
      • 6.3.6.1 Spain coronary stents market, 2016 - 2027 (USD Million)
  • 6.4 Asia Pacific
    • 6.4.1 Asia Pacific Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.4.2 Japan
      • 6.4.2.1 Japan coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.3 China
      • 6.4.3.1 China coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.4 India
      • 6.4.4.1 India coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.5 South Korea
      • 6.4.5.1 South Korea coronary stents market, 2016 - 2027 (USD Million)
    • 6.4.6 Australia
      • 6.4.6.1 Australia coronary stents market, 2016 - 2027 (USD Million)
  • 6.5 Latin America
    • 6.5.1 Latin America Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.5.2 Brazil
      • 6.5.2.1 Brazil coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.3 Mexico
      • 6.5.3.1 Mexico coronary stents market, 2016 - 2027 (USD Million)
    • 6.5.4 Argentina
      • 6.5.4.1 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • 6.6 MEA
    • 6.6.1 MEA Coronary Stents Market, 2016 - 2027 (USD Million)
    • 6.6.2 South Africa
      • 6.6.2.1 South Africa coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.3 Saudi Arabia
      • 6.6.3.1 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
    • 6.6.4 UAE
      • 6.6.4.1 UAE coronary stents market, 2016 - 2027 (USD Million)

Chapter 7 Company Profiles

  • 7.1 Abbott
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Medtronic
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 Boston Scientific Corporation
    • 7.3.1 Company Overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
    • 7.3.4 Strategic Initiatives
  • 7.4 Terumo Corporation
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 B Braun Melsungen AG
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 Biotronik
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Stentys SA
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 MicroPort Scientific Corporation
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 C. R. Bard, Inc.
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 Cook Medical
    • 7.10.1 Company Overview
    • 7.10.2 Product Benchmarking
    • 7.10.3 Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 CPT Coding
  • Table 4 HCPCS Coding
  • Table 5 CMS new reimbursement coding for PCI
  • Table 6 Product pipeline/clinical stage
  • Table 7 R&D expenditure analysis of public companies (2018)
  • Table 8 Leading market players anticipated to witness highest growth
  • Table 9 List of coronary stents service providers
  • Table 10 Leading cause of death in elderly population in the U.S. in 2019
  • Table 11 North America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 12 U.S. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 13 Canada Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 14 Europe Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 15 U.K. Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 16 Germany Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 17 France Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 18 Italy Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 19 Spain Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 20 Asia Pacific Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 21 Japan Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 22 China Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 23 India Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 24 South Korea Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 25 Australia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 26 Latin America Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 27 Brazil Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 28 Mexico Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 29 Argentina Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 30 MEA Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 31 South Africa Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 32 Saudi Arabia Coronary Stents market, by product, 2016 - 2027 (USD Million)
  • Table 33 UAE Coronary Stents market, by product, 2016 - 2027 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Commodity workflow analysis
  • Fig. 9 Market summary
  • Fig. 10 Coronary Stents market segmentation
  • Fig. 11 Parent Market Analysis
  • Fig. 12 Ancillary Market Analysis
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Incidence of CVDs in the U.S. in 2019
  • Fig. 15 Stent type and volume after price reduction in 2018
  • Fig. 16 Market restraint relevance analysis (Current & future impact)
  • Fig. 17 Penetration & growth prospect mapping
  • Fig. 18 Consumer behavior analysis
  • Fig. 19 Market influencer analysis
  • Fig. 20 Coronary Stents technology timeline
  • Fig. 21 R&D expenditure analysis (2014 - 2019)
  • Fig. 22 SWOT analysis, by PEST
  • Fig. 23 Porter's Five Forces Analysis
  • Fig. 24 Market participant categorization
  • Fig. 25 Competitive dashboard analysis
  • Fig. 26 Company market share analysis
  • Fig. 27 Company market position analysis
  • Fig. 28 Heat map analysis
  • Fig. 29 Coronary stents market product outlook: Key takeaways
  • Fig. 30 Coronary stents market: Product movement analysis
  • Fig. 31 Bare Metal Stents market, 2016 - 2027 (USD Million)
  • Fig. 32 Drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 33 Biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 34 Non-biodegradable drug eluting stents market, 2016 - 2027 (USD Million)
  • Fig. 35 Bioresorbable vascular scaffolds market, 2016 - 2027 (USD Million)
  • Fig. 36 Regional marketplace: Key takeaways
  • Fig. 37 Regional Outlook, 2019 & 2027
  • Fig. 38 North America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 39 U.S. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 40 Canada Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 41 Europe Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 42 U.K. coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 43 Germany coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 44 France coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 45 Number of individuals suffering from heart disease, 2010 - 2017
  • Fig. 46 Italy coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 47 Spain coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 48 Asia Pacific Coronary Stents market, 2016 - 2027 (USD Million)
  • Fig. 49 Japan coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 50 China coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 51 India coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 52 South Korea coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 53 Australia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 54 Latin America coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 55 Brazil coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 56 Mexico coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 57 Argentina coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 58 MEA coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 59 South Africa coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 60 Saudi Arabia coronary stents market, 2016 - 2027 (USD Million)
  • Fig. 61 UAE coronary stents market, 2016 - 2027 (USD Million)